BioVenic is a pioneering company dedicated to advancing animal research and development across multiple species. With a global presence, BioVenic offers a comprehensive suite of services designed to enhance animal health and well-being. Their diverse product range includes animal breeding and genetics solutions, such as genomic selection, animal reproduction support, and precision breeding technologies.

Additionally, BioVenic specializes in veterinary biologicals, offering veterinary antibodies, antigens, and a spectrum of diagnostic solutions tailored to various animal species, including companion animals and livestock. Their expertise extends to vaccine development, covering a wide array of formats from live attenuated to recombinant vaccines, along with veterinary therapeutics including custom antibodies and proteins.

Furthermore, BioVenic is committed to nutritional advancements through animal feed development and safety solutions, ensuring optimal nutrition for all animal types. Their ethical commitment to animal welfare is evident in their dedication to innovative research and genomic technologies, driving the industry forward while prioritizing animal welfare and food safety.